Media Library

Dr. Edward Garon reviews how certain drugs can change the landscape for treating patients with lung cancer. View Video ›

Dr. Edward Garon discusses the use of PD-1 and PD-L1 inhibitors in patients with lung cancer. View Video ›

Dr. Edward Garon does not believe there is much value in utilizing PD-L1 inhibitors for pateints with ALK gene rearrangement. View Video ›

Dr. Edward Garon speaks about how differences in patient populations with lung cancer can make it difficult to interpret and act on data. View Video ›

Dr. Edward Garon shares an anecdote about an interesting NSCLC case from his practice. View Video ›

Dr. Edward Garon explains how he discusses immunotherapies with patients. View Video ›

Dr. Edward Garon describes how staff at his practice interacts with patients. View Video ›

Dr. Edward Garon believes it's important to recognize that agents without efficacy are not beneficial to the patient despite low toxicity. View Video ›

In a recent interview with The Oncology Nurse-APN/PA (TON), Beth Faiman, PhD, APRN-BC, AOCN, Nurse Practitioner, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, and Editor-in-Chief of TON discussed her recent acceptance of a nomination for the Leukemia & Lymphoma Society (LLS) Woman of the Year award. View Video ›

Accreditation is important in setting standards. Dr. Bosserman explains, however, that as funding has dried up, fewer hospitals are willing to put up the money in pursuit of an accreditation that no one is requiring. View Video ›